Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Stocktwits on MSN
Why did ESPR stock surge 58% in pre-market today?
Esperion shareholders will receive $3.16 per share in cash at closing, a 58% premium to Thursday’s close. ・The acquisition is expected to close in the third quarter of 2026. ・ESPR shares are on track ...
The share price of Esperion Therapeutics ESPR lost 54.3% on Mar 16 after management reported a disagreement with one of its partners over certain milestone payments. Last year,Esperion announced that ...
The average one-year price target for Esperion Therapeutics (NasdaqGM:ESPR) has been revised to $2.97 / share. This is a decrease of 59.91% from the prior estimate of $7.40 dated April 25, 2026. The ...
We recently published These 10 Stocks are Winning Big. Esperion Therapeutics, Inc. (NASDAQ:ESPR) is one of the best-performing stocks on Monday. Esperion Therapeutics extended its winning streak to a ...
Esperion Therapeutics (ESPR) has been beaten down lately with too much selling pressure. While the stock has lost 51% over the past four weeks, there is light at the end of the tunnel as it is now in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results